CVE-2023-2978: Abstrium Pydio Cells

Medium severity, CVSS 4.3. EPSS: 0.7% chance of exploitation in the next 30 days.

A vulnerability was found in Abstrium Pydio Cells 4.2.0. It has been rated as problematic. Affected by this issue is some unknown functionality of the component Change Subscription Handler. The manipulation leads to authorization bypass. The exploit has been disclosed to the public and may be used. Upgrading to version 4.2.1 is able to address this issue. It is recommended to upgrade the affected component. VDB-230210 is the identifier assigned to this vulnerability.

Affected products

• Abstrium Pydio Cells: version 4.2.0 only

Published 2023-05-30. Last modified 2026-06-17.